These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28399570)

  • 1. Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases.
    Franklin JM; Schneeweiss S; Solomon DH
    Am J Epidemiol; 2017 Mar; 185(6):474-478. PubMed ID: 28399570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement.
    Solomon DH; Shadick NA; Weinblatt ME; Zak A; Frits M; Franklin JM
    Arthritis Res Ther; 2017 Jun; 19(1):130. PubMed ID: 28610614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
    Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
    Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential bias of instrumental variable analyses for observational comparative effectiveness research.
    Garabedian LF; Chu P; Toh S; Zaslavsky AM; Soumerai SB
    Ann Intern Med; 2014 Jul; 161(2):131-8. PubMed ID: 25023252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-study feasibility and identifying sensitivity analyses for protocol pre-specification in comparative effectiveness research.
    Girman CJ; Faries D; Ryan P; Rotelli M; Belger M; Binkowitz B; O'Neill R;
    J Comp Eff Res; 2014 May; 3(3):259-70. PubMed ID: 24969153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving rheumatoid arthritis comparative effectiveness research through causal inference principles: systematic review using a target trial emulation framework.
    Zhao SS; Lyu H; Solomon DH; Yoshida K
    Ann Rheum Dis; 2020 Jul; 79(7):883-890. PubMed ID: 32381560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.
    Neugebauer R; Schmittdiel JA; Zhu Z; Rassen JA; Seeger JD; Schneeweiss S
    Stat Med; 2015 Feb; 34(5):753-81. PubMed ID: 25488047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III.
    Johnson ML; Crown W; Martin BC; Dormuth CR; Siebert U
    Value Health; 2009; 12(8):1062-73. PubMed ID: 19793071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness research with administrative health data in rheumatoid arthritis.
    Hudson M; Tascilar K; Suissa S
    Nat Rev Rheumatol; 2016 Jun; 12(6):358-66. PubMed ID: 27080692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulations showed that validation of database-derived diagnostic criteria based on a small subsample reduced bias.
    Abrahamowicz M; Xiao Y; Ionescu-Ittu R; Lacaille D
    J Clin Epidemiol; 2007 Jun; 60(6):600-9. PubMed ID: 17493519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    van Dartel SA; Fransen J; Kievit W; Flendrie M; den Broeder AA; Visser H; Hartkamp A; van de Laar MA; van Riel PL
    Ann Rheum Dis; 2013 Jun; 72(6):895-900. PubMed ID: 22887849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus of recommendations guiding comparative effectiveness research methods.
    Morton JB; McConeghy R; Heinrich K; Gatto NM; Caffrey AR
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1354-1360. PubMed ID: 27365094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies.
    Yu M; Xie D; Wang X; Weiner MG; Tannen RL
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():60-8. PubMed ID: 22552981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of confounder in epidemiologic data contaminated by measurement error in covariates.
    Lee PH; Burstyn I
    BMC Med Res Methodol; 2016 May; 16():54. PubMed ID: 27193095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study).
    Mori S; Yoshitama T; Hidaka T; Hirakata N; Ueki Y
    Ann Rheum Dis; 2015 Mar; 74(3):627-30. PubMed ID: 25561361
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort.
    Kotak S; Mardekian J; Horowicz-Mehler N; Shah A; Burgess A; Kim J; Gemmen E; Boyd H; Koenig A
    Value Health; 2015 Sep; 18(6):817-23. PubMed ID: 26409609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement error and outcomes defined by exceeding a threshold: biased findings in comparative effectiveness trials.
    Bůžková P
    Pharm Stat; 2012; 11(6):429-41. PubMed ID: 22888090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bias formulas for external adjustment and sensitivity analysis of unmeasured confounders.
    Arah OA; Chiba Y; Greenland S
    Ann Epidemiol; 2008 Aug; 18(8):637-46. PubMed ID: 18652982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bias Formulas for Estimating Direct and Indirect Effects When Unmeasured Confounding Is Present.
    le Cessie S
    Epidemiology; 2016 Jan; 27(1):125-32. PubMed ID: 26426943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.